Back to companies

Bukwang Pharmaceutical Co Ltd: Premium Databases

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Bukwang Pharmaceutical Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

A sample of Bukwang Pharmaceutical Insights data

Headline Published Journalists
Showing 3 of 4 results.
Deserunt mollit sunt Lorem laborum do id aliqua dolore 08 Apr 2016 Lorem
Melior Discovery seeks partnership or USD 15m to advance dyskinesia drug to clinical proof of concept - CEO 09 Jul 2015 Hamish McDougall
LSK BioPharma seeks CRO for Phase IIb apatinib cancer trial – exec 09 Jun 2015 Katie McQue
Concit Pharma seeks 1H13 funding or partnership for levodopa-induced dyskinesia drug trial – executive 13 Dec 2012 Natalie Morrison
Insights

Feature

Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.

Benefit

Drug Insights:

  • Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
  • Material intelligence on competitors, including breaking news
  • Insight on companies’ business development needs and strategies

Outsourcing Insights:

Insight on companies’ CRO and business development needs, strategies and relationships

Value

Remove risk and uncertainty

Gain a competitive edge

Secure actionable leads

Premium databases is part of our industry range of products

Gain a 360-degree view of Bukwang Pharmaceutical Co Ltd and make more informed decisions for your business
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer